Pharmaceuticals

FDA Grants Fast Track Designation to Abdella Therapeutics’ Advanced Small Cell Lung Cancer Treatment

bexib
By bexib 0 Min Read

The new therapy, ABD-147, uses advanced antibody engineering to deliver actinium-225 to solid tumors expressing DLL3, a protein found in neuroendocrine tumors.

You Might Also Like

UK dementia organisations launch new manifesto ahead of general election

Behind the Big Pharma job cuts, is there an end in sight?

FDA Approves Vericel’s MACI for Arthroscopic Treatment of Cartilage Defects in the Knee

Amid weight-loss boom, drug companies seek edge with oral options

Pharma Pulse 8/7/24: Increase in mail-order pharmacies, decline in local pharmacies, etc.

Share This Article
Previous Article NoOnes Bitcoin Philosophy: Everybody Eats
Next Article Bitcoin Magazine and Look into Bitcoin Team Up to Release Enhanced Bitcoin Magazine Pro – Investorempires.com
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

5 fintech trends that will shake up Singapore in 2025
Fintech
Indonesia’s OJK issues new regulations on alternative credit scoring
Fintech
Donald Trump signs executive orders on trade on his first day in office
Manufacturing
Fifth Third expands branch network and doubles technology capabilities
Banking